Abstract:BackgroundEpithelial-to-mesenchymal transition (EMT) is a key step of the progression of tumor cell metastasis. Recent work has demonstrated some miRNAs play critical roles in EMT. In this study, we focused on the roles of miR-300 in regulating EMT.MethodsThe expression levels of miR-300 were examined in epithelial carcinoma cells that underwent an EMT using quantitative reverse transcription-PCR. The role of miR-300 in EMT was investigated by transfection of the miR-300 mimic or inhibitor in natural epithelial-mesenchymal phenotype cell line pairs and in transforming growth factor (TGF) beta-induced EMT cell models. A luciferase reporter assay and a rescue experiment were conducted to confirm the target gene of miR-300. The efficacy of miR-300 against tumor invasion and metastasis was evaluated both in vitro and in vivo. Correlation analysis between miR-300 expression and the expression levels of its target gene, as well as tumor metastasis was performed in specimens from patients with head and neck squamous cell carcinoma (HNSCC).ResultsMiR-300 was found down-regulated in the HNSCC cells and breast cancer cells that underwent EMT. Ectopic expression of miR-300 effectively blocked TGF-beta-induced EMT and reversed the phenotype of EMT in HN-12 and MDA-MB-231 cells, but inhibition of miR-300 in the epithelial phenotype cells, HN-4 and MCF-7 cells, could induce EMT. The luciferase reporter assay and the rescue assay results showed that miR-300 directly targets the 3′UTR of Twist. Enforced miR-300 expression suppressed cell invasion in vitro and experimental metastasis in vivo. Clinically, miR-300 expression was found inversely correlated with Twist expression and reduced miR-300 was associated with metastasis in patient specimens.ConclusionsDown-regulation of miR-300 is required for EMT initiation and maintenance. MiR-300 may negatively regulate EMT by direct targeting Twist and therefore inhibit cancer cell invasion and metastasis, which implicates miR-300 as an attractive candidate for cancer therapy.

The Role of TWIST1 in Epithelial-Mesenchymal Transition and Cancers

AKT-ions with a TWIST between EMT and MET.

Expression of Twist-1 promotes lymph node metastasis of gastric cancer cells

Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms

TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance

Stem-cell-like Properties and Epithelial Plasticity Arise As Stable Traits after Transient Twist1 Activation.

Twist Regulation of EMT and Its Clinical Significance in Monitoring Circulating Tumor Cells and Evaluating Effects of Anticancer Drugs

TWIST1 Plays Role in Expression of Stemness State Markers in ESCC

Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression

An Overview of Twist1 in Glioma Progression and Recurrence.

The Role of XBP1s in the Metastasis and Prognosis of Hepatocellular Carcinoma

EMT Mediated Cancer Stemness and Tumor

Significance of TWIST Expression and Its Association with E-cadherin in Bladder Cancer

ZNF451 Stabilizes TWIST2 Through SUMOylation and Promotes Epithelial-Mesenchymal Transition.

Twist Mediates an Aggressive Phenotype in Human Colorectal Cancer Cells.

MiR-526b Suppresses Cell Proliferation, Cell Invasion and Epithelial-Mesenchymal Transition in Breast Cancer by Targeting Twist1

Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer

SET8 Promotes Epithelial-Mesenchymal Transition and Confers TWIST Dual Transcriptional Activities.

Twist1-mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells.

TWIST1 Drives Cytotoxic CD8+ T-Cell Exhaustion through Transcriptional Activation of CD274 (PD-L1) Expression in Breast Cancer Cells

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer